Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil in Fragile X Syndrome
NCT01120626Phase 2Completed
- Sponsor
- Stanford University
- Start
- Sep 2009
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Fragile X syndrome (FXS) comparing Donepezil with Placebo (2 arms). Primary endpoint: Contingency Naming Test Performance Score at Week 12. Started Sep 2009; status: completed.
02
Drugs
donepezil
03
Conditions
Fragile X syndrome (FXS)
Beyond the preview
Go deeper on NCT01120626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01120626.